Your browser doesn't support javascript.
loading
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.
Wilson, Darrell M; Pietropaolo, Susan L; Acevedo-Calado, Maria; Huang, Shuai; Anyaiwe, Destiny; Scheinker, David; Steck, Andrea K; Vasudevan, Madhuri M; McKay, Siripoom V; Sherr, Jennifer L; Herold, Kevan C; Dunne, Jessica L; Greenbaum, Carla J; Lord, Sandra M; Haller, Michael J; Schatz, Desmond A; Atkinson, Mark A; Nelson, Patrick W; Pietropaolo, Massimo.
Afiliação
  • Wilson DM; 1Division of Pediatric Endocrinology, Stanford University School of Medicine, Palo Alto, CA.
  • Pietropaolo SL; 2Division of Endocrinology, Diabetes, and Metabolism, Diabetes Research Center, Department of Medicine, Baylor College of Medicine, Houston, TX.
  • Acevedo-Calado M; 2Division of Endocrinology, Diabetes, and Metabolism, Diabetes Research Center, Department of Medicine, Baylor College of Medicine, Houston, TX.
  • Huang S; 3Department of Industrial & Systems Engineering, University of Washington, Seattle, WA.
  • Anyaiwe D; 4Department of Mathematics & Computer Science, Lawrence Technological University, Southfield, MI.
  • Scheinker D; 1Division of Pediatric Endocrinology, Stanford University School of Medicine, Palo Alto, CA.
  • Steck AK; 5Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Vasudevan MM; 2Division of Endocrinology, Diabetes, and Metabolism, Diabetes Research Center, Department of Medicine, Baylor College of Medicine, Houston, TX.
  • McKay SV; 2Division of Endocrinology, Diabetes, and Metabolism, Diabetes Research Center, Department of Medicine, Baylor College of Medicine, Houston, TX.
  • Sherr JL; 6Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Herold KC; 7Division of Pediatric Endocrinology, Yale University School of Medicine, New Haven, CT.
  • Dunne JL; 8Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT.
  • Greenbaum CJ; 9JDRF, New York, NY.
  • Lord SM; 10Center for Interventional Immunology and Diabetes Program, Benaroya Research Institute, Seattle, WA.
  • Haller MJ; 10Center for Interventional Immunology and Diabetes Program, Benaroya Research Institute, Seattle, WA.
  • Schatz DA; 11Department of Pediatrics, University of Florida Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL.
  • Atkinson MA; 11Department of Pediatrics, University of Florida Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL.
  • Nelson PW; 11Department of Pediatrics, University of Florida Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL.
  • Pietropaolo M; 4Department of Mathematics & Computer Science, Lawrence Technological University, Southfield, MI.
Diabetes Care ; 46(3): 526-534, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36730530

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Limite: Adolescent / Female / Humans / Male Idioma: En Revista: Diabetes Care Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Limite: Adolescent / Female / Humans / Male Idioma: En Revista: Diabetes Care Ano de publicação: 2023 Tipo de documento: Article